Transplant Diagnostics Market Scenario
Increasing number of transplant procedures, technological advancements in the field of transplant diagnostics and increasing public-private funding for target research activities are some of the major factors propelling the transplant diagnostics market globally. Furthermore, growing burden of infectious diseases is also one of the factor propelling the growth of transplant diagnostics market. However, high procedural cost of NGS and PCR-based diagnostic assays is one of the major factor expected to hamper the global growth of the market.
Transplant Diagnostics Market Segmentation
The transplant diagnostics market is segmented by product and services, technology, transplant type, application, end user and geography. The product and services studied in the transplant diagnostics market are reagents and consumables, instruments and software and services. Various technology studied in the transplant diagnostics market are Molecular Assays (PCR-Based Molecular Assays (Real-Time PCR, Sequence-Specific Primer-PCR, Sequence-Specific Oligonucleotide-PCR and Other PCR-Based Molecular Assays), Sequencing-Based Molecular Assays (Sanger Sequencing, Next-Generation Sequencing and Other Sequencing Molecular Assays) and Non-Molecular Assays (Serological Assay and Mixed Lymphocyte Culture Assay). Transplant type comprises of solid organ transplant (kidney transplant, liver transplant, heart transplant, lung transplant, pancreas transplant and other organ transplantations), stem cell transplant and soft tissue transplant. Various applications of transplant diagnostics are diagnostic applications (pre-transplantation diagnostics (infectious disease testing, histocompatibility testing and blood profiling) and post-transplantation diagnostics) and research applications. Transplant diagnostics are used in various end user such as independent reference laboratories, hospitals & transplant centers and research laboratories & academic institutes. Based on Geography, the Transplant diagnostics Market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW.
Transplant Diagnostics Market by Geography
Based on geography, the transplant diagnostics market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the North America is anticipated to hold the major share of the global transplant diagnostics market. Major drivers include high adoption of advanced techniques and diagnostic tools, higher healthcare expenditure, and availability of skilled professionals. U.S. holds the largest market share owing to factors such as highly developed healthcare infrastructure and availability of skilled professionals.
Transplant Diagnostics Market Key Players
Some of the major players operating in the global transplant diagnostics market includes Becton, Dickinson and Company, Biofortuna, Biomérieux SA, Bio-Rad Laboratories, Caredx, F. Hoffman-La Roche Limited, Gendx, Hologic, Illumina Immucor, Luminex, Merck KGaA, Omixon, Qiagen and Thermo Fisher Scientific. Many companies in this market implement initiatives such as mergers and acquisitions, product developments, and geographic penetration to compete in the market. Players are implementing strategies, such as long-term contracts with diagnostic clinics and laboratories and discount pricing for bulk purchases.
Transplant Diagnostics Market Report Key Benefits